Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector

Jahangir Khan,1–3 Sajid Bashir,1 Muhammad Asif Khan,4 Mohammad Amin Mohammad,3 Mohammad Isreb3 1Department of Pharmacy, Faculty of Pharmacy, University of Sargodha, Sargodha, Pakistan; 2Department of Pharmacy, University of Malakand, Dīr, Khyber Pakhtunkhwa, Pakistan; 3School of Pharmacy,...

Full description

Bibliographic Details
Main Authors: Khan J, Bashir S, Khan MA, Mohammad MA, Isreb M
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/fabrication-and-characterization-of-dexibuprofen-nanocrystals-using-mi-peer-reviewed-article-DDDT
_version_ 1819263547029323776
author Khan J
Bashir S
Khan MA
Mohammad MA
Isreb M
author_facet Khan J
Bashir S
Khan MA
Mohammad MA
Isreb M
author_sort Khan J
collection DOAJ
description Jahangir Khan,1–3 Sajid Bashir,1 Muhammad Asif Khan,4 Mohammad Amin Mohammad,3 Mohammad Isreb3 1Department of Pharmacy, Faculty of Pharmacy, University of Sargodha, Sargodha, Pakistan; 2Department of Pharmacy, University of Malakand, Dīr, Khyber Pakhtunkhwa, Pakistan; 3School of Pharmacy, Institute of Life Science Research, School of Pharmacy, University of Bradford, Bradford, UK; 4Department of Pharmacy, Sarhad University Peshawar, Peshawar, Pakistan Purpose: Dexibuprofen is an enantiomer of ibuprofen with low bioavailability which results from its hydrophobic nature. Nanosuspensions have developed a podium to solve the in vitro dissolution problem that frequently occurs in current research. Materials and methods: The drug and polymer solutions were mixed in a microchannel fluid reactor and the successive embryonic nanosuspension was decanted into a vial having the polymer solution. The impact of different process and formulation parameters including inlet angle, antisolvent and solvent flow rate(s), mixing time, drug concentration, polymer type and concentration was evaluated. Results and discussion: Stable dexibuprofen nanocrystals with a particle size of 45±3.0 nm and polydispersity index of 0.19±0.06 were obtained. Differential scanning calorimetry and powder X-ray diffraction confirmed the crystallinity. The key parameters observed were inlet angle 10°, antisolvent to solvent volume of 2.0/0.5 mL/min, 60 minutes mixing with 5 minutes sonication, Poloxamer-407 with a concentration of 0.5% w/v and drug concentration (5 mg/mm). The 60-day stability studies revealed that the nanocrystals were stable at 4°C and 25°C. The scanning electron microscopy and transmission electron microscopy images showed crystalline morphology with a homogeneous distribution. Conclusion: Stable dexibuprofen nanocrystals with retentive distinctive characteristics and having marked dissolution rate compared to raw and marketed formulations were efficiently fabricated. In future perspectives, these nanocrystals could be converted to solid dosage form and the process can be industrialized by chemical engineering approach. Keywords: nanocrystal, dexibuprofen, microchannel fluidic reactor, process and formulation parameters
first_indexed 2024-12-23T20:15:19Z
format Article
id doaj.art-1ee1d8a104ac4561a5bfde8b35687140
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-12-23T20:15:19Z
publishDate 2018-08-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-1ee1d8a104ac4561a5bfde8b356871402022-12-21T17:32:42ZengDove Medical PressDrug Design, Development and Therapy1177-88812018-08-01Volume 122617262640180Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rectorKhan JBashir SKhan MAMohammad MAIsreb MJahangir Khan,1–3 Sajid Bashir,1 Muhammad Asif Khan,4 Mohammad Amin Mohammad,3 Mohammad Isreb3 1Department of Pharmacy, Faculty of Pharmacy, University of Sargodha, Sargodha, Pakistan; 2Department of Pharmacy, University of Malakand, Dīr, Khyber Pakhtunkhwa, Pakistan; 3School of Pharmacy, Institute of Life Science Research, School of Pharmacy, University of Bradford, Bradford, UK; 4Department of Pharmacy, Sarhad University Peshawar, Peshawar, Pakistan Purpose: Dexibuprofen is an enantiomer of ibuprofen with low bioavailability which results from its hydrophobic nature. Nanosuspensions have developed a podium to solve the in vitro dissolution problem that frequently occurs in current research. Materials and methods: The drug and polymer solutions were mixed in a microchannel fluid reactor and the successive embryonic nanosuspension was decanted into a vial having the polymer solution. The impact of different process and formulation parameters including inlet angle, antisolvent and solvent flow rate(s), mixing time, drug concentration, polymer type and concentration was evaluated. Results and discussion: Stable dexibuprofen nanocrystals with a particle size of 45±3.0 nm and polydispersity index of 0.19±0.06 were obtained. Differential scanning calorimetry and powder X-ray diffraction confirmed the crystallinity. The key parameters observed were inlet angle 10°, antisolvent to solvent volume of 2.0/0.5 mL/min, 60 minutes mixing with 5 minutes sonication, Poloxamer-407 with a concentration of 0.5% w/v and drug concentration (5 mg/mm). The 60-day stability studies revealed that the nanocrystals were stable at 4°C and 25°C. The scanning electron microscopy and transmission electron microscopy images showed crystalline morphology with a homogeneous distribution. Conclusion: Stable dexibuprofen nanocrystals with retentive distinctive characteristics and having marked dissolution rate compared to raw and marketed formulations were efficiently fabricated. In future perspectives, these nanocrystals could be converted to solid dosage form and the process can be industrialized by chemical engineering approach. Keywords: nanocrystal, dexibuprofen, microchannel fluidic reactor, process and formulation parametershttps://www.dovepress.com/fabrication-and-characterization-of-dexibuprofen-nanocrystals-using-mi-peer-reviewed-article-DDDTNanocrystalDexibuprofenMicrochannel Fluidic ReactorProcess & formulation parameters
spellingShingle Khan J
Bashir S
Khan MA
Mohammad MA
Isreb M
Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector
Drug Design, Development and Therapy
Nanocrystal
Dexibuprofen
Microchannel Fluidic Reactor
Process & formulation parameters
title Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector
title_full Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector
title_fullStr Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector
title_full_unstemmed Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector
title_short Fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector
title_sort fabrication and characterization of dexibuprofen nanocrystals using microchannel fluidic rector
topic Nanocrystal
Dexibuprofen
Microchannel Fluidic Reactor
Process & formulation parameters
url https://www.dovepress.com/fabrication-and-characterization-of-dexibuprofen-nanocrystals-using-mi-peer-reviewed-article-DDDT
work_keys_str_mv AT khanj fabricationandcharacterizationofdexibuprofennanocrystalsusingmicrochannelfluidicrector
AT bashirs fabricationandcharacterizationofdexibuprofennanocrystalsusingmicrochannelfluidicrector
AT khanma fabricationandcharacterizationofdexibuprofennanocrystalsusingmicrochannelfluidicrector
AT mohammadma fabricationandcharacterizationofdexibuprofennanocrystalsusingmicrochannelfluidicrector
AT isrebm fabricationandcharacterizationofdexibuprofennanocrystalsusingmicrochannelfluidicrector